Circular RNAs: Insights into Clinical and Therapeutic Approaches for Various Cancers

Ikram Ul Haq1,2, Fatima Akram1, Narmeen Nasir1

  • 1Institute of Industrial Biotechnology, Government College University, Lahore, 54000, Pakistan.

Abstract

Insights

Circular RNAs (circRNAs) are key gene regulators implicated in cancer. Their abnormal expression offers potential as biomarkers and therapeutic targets for disease diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are endogenous noncoding RNAs formed by exon back-splicing of pre-mRNAs.
  • They are widely distributed in eukaryotic cell transcriptomes and regulate gene expression and cellular functions.
  • Their roles are increasingly recognized in cancer diagnostics and therapeutics.

Approach:

  • This review discusses the functional mechanisms of circRNAs.
  • It explores their potential as biomarkers for disease diagnosis and prognosis.
  • Therapeutic strategies and limitations associated with circRNAs are also examined.

Key Points:

  • circRNAs function as microRNA sponges, protein scaffolds, and modulators of transcription and splicing.
  • Abnormal circRNA expression is prevalent in malignancies, promoting proliferation, invasiveness, and inhibiting cell death.
  • These characteristics highlight circRNAs as promising clinical biomarkers and therapeutic targets.

Conclusions:

  • Understanding circRNA mechanisms is crucial for identifying novel biomarkers and therapeutic targets.
  • circRNAs hold significant promise in the diagnosis and therapy of various diseases.
  • Further research is needed to overcome limitations and fully exploit their therapeutic potential.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K